Meeting
2016 ASCO Annual Meeting
A phase I study of afatinib combined with carboplatin or carboplatin plus paclitaxel in patients (pts) with advanced solid tumors.
Authors
Fangfei Gao
Kings College London, Guys Hospital, London, United Kingdom
Fangfei Gao , Mary O'Brien , Debashis Sarker , Jaishree Bhosle , Timothy Anthony Yap , Martina Maria Uttenreuther-Fischer , Karine Pemberton , Rainer-Georg Goeldner , Sabrina Wiebe , Johann S. De Bono , Johann de Bono , James F. Spicer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics
Track
Developmental Therapeutics and Translational Research
Sub Track
Small Molecules
Clinical Trial Registration Number
NCT00809133
Citation
J Clin Oncol 34, 2016 (suppl; abstr 2571)
DOI
10.1200/JCO.2016.34.15_suppl.2571
Abstract #
2571
Poster Bd #
271
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.
First Author: Nancy Chan
Poster
2023 ASCO Annual Meeting
Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors.
First Author: Chia-Chi Lin
Poster
2020 ASCO Virtual Scientific Program
Phase I study of the combination of alisertib (MLN8237) and gemcitabine in advanced solid tumors.
First Author: Jasmine Huynh
Poster
2019 ASCO Annual Meeting
Phase I trial of chloroquine (CQ)/hydroxychloroquine (HCQ) in combination with carboplatin-gemcitabine (CG) in patients with advanced solid tumors.
First Author: Nagla Fawzy Abdel Karim